ArticleDer Nervenarzt2021
[Neurological symptoms associated with cancer treatment].
Article in Der Nervenarzt, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Bilateral carpal tunnel syndrome in a patient with malignant melanoma undergoing adjuvant pembrolizumab therapy].Dermatologie (Heidelberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic treatment in oncology has become more biomarker-based, molecularly tailored and effective. Building on increasing scientific insights into cell biological and molecular mechanisms, the number of targeted drug therapies is also increasing. There is also an increase in the number of long-term survivors. Neuro(onco)logical care is becoming increasingly more important, not only because of increased direct tumor-related symptoms, such as higher incidence of central nervous system metastases, but also because a broad spectrum of treatment-associated neurological symptoms occur during the course of these modern oncological systemic therapies, which require careful and fast neurological/neuro-oncological evaluation and treatment. The goal of this article is to raise awareness of the most common treatment-associated neurologic symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.